161 related articles for article (PubMed ID: 23261548)
1. Risk of subsequent primary malignancies after dermatofibrosarcoma protuberans diagnosis: a national study.
Kurlander DE; Martires KJ; Chen Y; Barnholtz-Sloan JS; Bordeaux JS
J Am Acad Dermatol; 2013 May; 68(5):790-6. PubMed ID: 23261548
[TBL] [Abstract][Full Text] [Related]
2. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.
Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129
[TBL] [Abstract][Full Text] [Related]
3. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
Spanogle JP; Clarke CA; Aroner S; Swetter SM
J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
[TBL] [Abstract][Full Text] [Related]
4. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of dermatofibrosarcoma protuberans in Alberta, Canada, from 1988 to 2007.
Kuzel P; Metelitsa AI; Dover DC; Salopek TG
Dermatol Surg; 2012 Sep; 38(9):1461-8. PubMed ID: 22691126
[TBL] [Abstract][Full Text] [Related]
6. Dermatofibrosarcoma protuberans: a population-based cancer registry descriptive study of 66 consecutive cases diagnosed between 1982 and 2002.
Monnier D; Vidal C; Martin L; Danzon A; Pelletier F; Puzenat E; Algros MP; Blanc D; Laurent R; Humbert PH; Aubin F
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1237-42. PubMed ID: 17062038
[TBL] [Abstract][Full Text] [Related]
7. Incidence and Survival of Primary Dermatofibrosarcoma Protuberans in the United States.
Kreicher KL; Kurlander DE; Gittleman HR; Barnholtz-Sloan JS; Bordeaux JS
Dermatol Surg; 2016 Jan; 42 Suppl 1():S24-31. PubMed ID: 26730971
[TBL] [Abstract][Full Text] [Related]
8. Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin.
Balamurugan A; Rees JR; Kosary C; Rim SH; Li J; Stewart SL
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S69-77. PubMed ID: 22018070
[TBL] [Abstract][Full Text] [Related]
9. Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
Kaae J; Hansen AV; Biggar RJ; Boyd HA; Moore PS; Wohlfahrt J; Melbye M
J Natl Cancer Inst; 2010 Jun; 102(11):793-801. PubMed ID: 20424236
[TBL] [Abstract][Full Text] [Related]
10. Effect of Non-Hodgkin Lymphoma on Survival in Patients With Malignant Fibrous Histiocytoma, Kaposi Sarcoma, and Sebaceous Carcinoma: A SEER Population-Based Study.
Brewer JD; Shanafelt TD; Cerhan JR; Call TG; Weaver AL; Otley CC
Dermatol Surg; 2016 Jan; 42 Suppl 1():S32-9. PubMed ID: 26730972
[TBL] [Abstract][Full Text] [Related]
11. Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009.
Jung GW; Dover DC; Salopek TG
Br J Dermatol; 2014 Jan; 170(1):136-43. PubMed ID: 24443913
[TBL] [Abstract][Full Text] [Related]
12. Second primary ovarian cancer among women diagnosed previously with cancer.
Hall HI; Jamison P; Weir HK
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):995-9. PubMed ID: 11535553
[TBL] [Abstract][Full Text] [Related]
13. Incidence of second malignancies after external beam radiotherapy for clinical stage I testicular seminoma.
Lewinshtein D; Gulati R; Nelson PS; Porter CR
BJU Int; 2012 Mar; 109(5):706-12. PubMed ID: 21883828
[TBL] [Abstract][Full Text] [Related]
14. Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer.
Yang GB; Barnholtz-Sloan JS; Chen Y; Bordeaux JS
Arch Dermatol; 2011 Dec; 147(12):1395-402. PubMed ID: 22184761
[TBL] [Abstract][Full Text] [Related]
15. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.
Shah BK; Khanal A
Anticancer Res; 2015 Jun; 35(6):3437-40. PubMed ID: 26026107
[TBL] [Abstract][Full Text] [Related]
16. The risk of developing second cancers among survivors of childhood soft tissue sarcoma.
Cohen RJ; Curtis RE; Inskip PD; Fraumeni JF
Cancer; 2005 Jun; 103(11):2391-6. PubMed ID: 15852362
[TBL] [Abstract][Full Text] [Related]
17. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
18. Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery.
Paradisi A; Abeni D; Rusciani A; Cigna E; Wolter M; Scuderi N; Rusciani L; Kaufmann R; Podda M
Cancer Treat Rev; 2008 Dec; 34(8):728-36. PubMed ID: 18684568
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous soft tissue sarcoma incidence patterns in the U.S. : an analysis of 12,114 cases.
Rouhani P; Fletcher CD; Devesa SS; Toro JR
Cancer; 2008 Aug; 113(3):616-27. PubMed ID: 18618615
[TBL] [Abstract][Full Text] [Related]
20. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
